Combination of atezolizumab and chidamide to maintain long-term remission in refractory metastatic extranodal natural killer/T-cell lymphoma: A case report

BACKGROUND: The prognosis of refractory extranodal natural killer/T-cell lymphoma (ENKTL) is poor. Recent data have indicated that immune checkpoint blockade with a programmed cell death protein-1 (PD-1) antibody in combination with administration of histone deacetylase inhibitors represents a poten...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Juan, Gao, Yong-Sheng, Xu, Kun, Li, Xiao-Dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8855270/
https://www.ncbi.nlm.nih.gov/pubmed/35211600
http://dx.doi.org/10.12998/wjcc.v10.i5.1609

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8855270/
https://www.ncbi.nlm.nih.gov/pubmed/35211600
http://dx.doi.org/10.12998/wjcc.v10.i5.1609

Ejemplares similares